Picture of MiMedx logo

MDXG MiMedx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapContrarian

MiMedx Group Inc reports results for the quarter ended in March - Earnings Summary

* MiMedx Group Inc  MDXG.OQ  reported a quarterly adjusted
loss
of 6 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 9 cents per share.
    * Revenue rose 21.7% to $71.68 million from a year ago;
analysts
expected $64.15 million. 
    * MiMedx Group Inc's reported EPS for the quarter was a loss
of 6
cents​.
    * The mean earnings estimate of analysts had risen by
about 27.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * MiMedx Group Inc shares had risen by 12.9% this
quarter and
gained 38.5% so far this year.
    * The company reported a quarterly loss of $6.67 million.
    * Wall Street's median 12-month price target for MiMedx
Group Inc
is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
2 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.09          -0.06          Beat
 Dec. 31 2022      -0.04          -0.02          Beat
 Sep. 30 2022      -0.08          -0.09          Missed
 Jun. 30 2022      -0.06          -0.11          Missed

Recent news on MiMedx

See all news